Kaplan–Meier curves revealed survival differences based on early clonal mutations in lung adenocarcinoma patients, indicating significant clinical implications.
Kaplan–Meier survival curves comparing the clinical outcome of patients with a high level of early clonal mutations (among the top 10% of the proportion of early clonal mutations) versus others in the TCGA and NHLCC cohort.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: